---
input_text: 'Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation
  for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the
  EBMT. Allogeneic hematopoietic cell transplantation (HCT) is the only curative option
  for bone marrow failure or hematopoietic malignant diseases for Fanconi anemia (FA)
  patients. Although results have improved over the last decades, reaching more than
  90% survival when a human leukocyte antigen (HLA)-identical donor is available,
  alternative HCT donors are still less reported. We compared HCT outcomes using HLA-mismatched
  unrelated donors (MMUD; n = 123) or haplo-identical donors (HDs), either using only
  in vivo T cell depletion (n = 33) or T cells depleted in vivo with some type of
  graft manipulation ex vivo (n = 59) performed for FA between 2000 and 2018. Overall
  survival (OS) by 24 months was 62% (53-71%) for MMUD, versus 80% (66-95%) for HDs
  with only in vivo T cell depletion and 60% (47-73%) for HDs with in vivo and ex
  vivo T cell depletion (p = .22). Event-free survival (EFS) was better for HD-transplanted
  FA patients with only in vivo T cell depletion 86% (73-99%) than for those transplanted
  from a MMUD 58% (48-68%) or those with graft manipulation 56% (42-69%) (p = .046).
  Grade II-IV acute graft-versus-host disease (GVHD) was 41% (MMUD) versus 40% (HDs
  with no graft manipulation) versus 17% (HDs with T cell depleted graft), (p = .005).
  No differences were found for the other transplant related outcomes. These data
  suggest that HDs might be considered as an alternative option for FA patients with
  better EFS using unmanipulated grafts.'
raw_completion_output: |-
  primary_disease: Fanconi anemia

  medical_actions: Allogeneic hematopoietic cell transplantation (HCT); T cell depletion; graft manipulation

  symptoms: bone marrow failure; hematopoietic malignant diseases

  chemicals: 

  action_annotation_relationships: Allogeneic hematopoietic cell transplantation (HCT) TREATS bone marrow failure IN Fanconi anemia; Allogeneic hematopoietic cell transplantation (HCT) TREATS hematopoietic malignant diseases IN Fanconi anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Allogeneic hematopoietic cell transplantation (HCT) TREATS hematopoietic malignant diseases IN Fanconi anemia

  ===

extracted_object:
  primary_disease: MONDO:0019391
  medical_actions:
    - MAXO:0000149
    - T cell depletion
    - graft manipulation
  symptoms:
    - HP:0005528
    - hematopoietic malignant diseases
  action_annotation_relationships:
    - subject: Allogeneic hematopoietic cell transplantation
      predicate: TREATS
      object: HP:0005528
      qualifier: MONDO:0019391
      subject_extension: Allogeneic hematopoietic cell transplantation (HCT)
    - subject: MAXO:0000149
      predicate: TREATS
      object: hematopoietic malignant diseases
      qualifier: MONDO:0019391
named_entities:
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: CHEBI:18198
    label: ADCs
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: CHEBI:37153
    label: Calcineurin inhibitor
  - id: CHEBI:38215
    label: Calcium channel blocker
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8069
    label: Phenobarbital
  - id: CHEBI:2668
    label: Amlodipine
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000016
    label: Cellular therapy
  - id: HP:0001871
    label: Blood dyscrasias
  - id: MAXO:0000595
    label: Radiography
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0034057
    label: Congenital defects
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:44185
    label: Methotrexate
  - id: MONDO:0005233
    label: Non-small cell lung cancer (NSCLC)
  - id: CHEBI:33364
    label: Platinum
  - id: MAXO:0000647
    label: chemotherapy
  - id: HP:0030358
    label: Non-small cell lung cancer
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0002863
    label: Myelodysplasia
  - id: HP:0001909
    label: Leukemia
  - id: MONDO:0016624
    label: Hereditary anemia
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005570
    label: Hematological disorders
  - id: HP:0002664
    label: cancer
  - id: MONDO:0015253
    label: Diamond Blackfan anemia
  - id: MAXO:0000600
    label: Kidney replacement therapy (KRT)
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003259
    label: Elevated serum creatinine (SCr > 100micromol/l)
  - id: MONDO:0001529
    label: Bone marrow failure (BMF)
  - id: HP:0002860
    label: oral squamous cell carcinoma (SCC)
  - id: MONDO:0100339
    label: Fanconi anemia (FA)
  - id: CHEBI:28680
    label: Ara-C
  - id: CHEBI:27899
    label: Cisplatin
  - id: HP:0011793
    label: Malignant tumors
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0002745
    label: Oral leukoplakia
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0002910
    label: elevated liver function tests
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:231614
    label: Nivolumab
  - id: CHEBI:25016
    label: PBS
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:28876
    label: Melphalan
  - id: CHEBI:229764
    label: Selinexor
  - id: CHEBI:229762
    label: Eltanexor
  - id: HP:0006775
    label: Multiple Myeloma
  - id: CHEBI:229763
    label: exportin 1 inhibitors
  - id: MONDO:0015909
    label: aplastic anemia
  - id: HP:0004808
    label: Acute myeloid leukaemia
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MONDO:0001881
    label: Septic shock
  - id: MAXO:0001021
    label: Antimicrobial treatment
  - id: MAXO:0000174
    label: Antifungal treatment
  - id: HP:0001876
    label: Pancytopenia
  - id: HP:0001945
    label: Fever
  - id: CHEBI:133748
    label: Citrate
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:33281
    label: Antimicrobial
  - id: CHEBI:35718
    label: Antifungal
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome (PRES)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0001188
    label: Laparoscopy
  - id: HP:0000988
    label: Skin rash
  - id: MONDO:0010161
    label: Tyrosinemia Type 1
  - id: HP:0001919
    label: acute kidney injury (AKI)
  - id: HP:0000822
    label: hypertension
  - id: MAXO:0001298
    label: therapy
  - id: HP:0040012
    label: Increased chromosomal breakage
  - id: MONDO:0004631
    label: Tongue cancer (TC)
  - id: CHEBI:4735
    label: EDTA
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0025085
    label: Blood in stool
  - id: HP:0000568
    label: Microphthalmia
  - id: HP:0000482
    label: microcornea
  - id: HP:0000508
    label: ptosis
  - id: HP:0011496
    label: limbal neovascularization
  - id: HP:0001097
    label: keratoconjunctivitis sicca
  - id: CHEBI:62932
    label: Mycophenolate
  - id: MONDO:0008903
    label: Lung Cancer
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0032169
    label: severe infections
